• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型冠状病毒肺炎与急性心肌炎:当前文献综述及诊断挑战

COVID-19 and acute myocarditis: current literature review and diagnostic challenges.

作者信息

Çınar Tufan, Hayıroğlu Mert İlker, Çiçek Vedat, Uzun Mehmet, Orhan Ahmet Lütfullah

机构信息

. Department of Cardiology, Haydarpasa Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey.

. Department of Cardiology, Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital, Istanbul, Turkey.

出版信息

Rev Assoc Med Bras (1992). 2020 Sep 21;66Suppl 2(Suppl 2):48-54. doi: 10.1590/1806-9282.66.S2.48. eCollection 2020.

DOI:10.1590/1806-9282.66.S2.48
PMID:32965356
Abstract

INTRODUCTION

In the current literature, there has been an upsurge of cases of COVID-19-induced acute myocarditis. In this case-based review, we aimed to describe the clinical characteristics, imaging findings, and in-hospital course of acute myocarditis. In addition, the limitations of the myocarditis diagnosis were discussed since only fulminant myocarditis cases have been mentioned in the current literature.

METHODS

We performed a review of the literature of all patients who were diagnosed with COVID-19-induced acute myocarditis using the databases of PubMed, Embase, and the Cochrane.

RESULTS

16 case reports were found to be related to COVID-19-induced acute myocarditis. We observed that the ECG findings in most of the COVID-19 patients were non-specific, including diffuse ST-segment elevation, non-specific intraventricular conduction delay, sinus tachycardia, and inverted T-waves in anterior leads. Echocardiographic findings of COVID-19-induced acute myocarditis patients ranged from preserved left ventricular ejection fraction (LVEF) without segmental abnormalities to reduced LVEF with global hypokinesia. Interestingly, a few patients with COVID-19-induced acute fulminant myocarditis were steroid-responsive and had an amelioration with glucocorticoid and immunoglobulin therapy.

CONCLUSION

Despite the COVID-19 pandemic worldwide, a limited number of cases has been shared in the current literature. There are a lot of difficulties in the differential diagnosis of acute myocarditis in the context of COVID-19.

摘要

引言

在当前文献中,由新冠病毒感染引起的急性心肌炎病例激增。在本病例回顾中,我们旨在描述急性心肌炎的临床特征、影像学表现及住院病程。此外,鉴于当前文献仅提及暴发性心肌炎病例,我们还讨论了心肌炎诊断的局限性。

方法

我们使用PubMed、Embase和Cochrane数据库,对所有被诊断为新冠病毒感染引起的急性心肌炎患者的文献进行了回顾。

结果

发现16例病例报告与新冠病毒感染引起的急性心肌炎有关。我们观察到,大多数新冠病毒感染患者的心电图表现无特异性,包括弥漫性ST段抬高、非特异性室内传导延迟、窦性心动过速以及前壁导联T波倒置。新冠病毒感染引起的急性心肌炎患者的超声心动图表现范围从左心室射血分数(LVEF)正常且无节段性异常到LVEF降低且整体运动减弱。有趣的是,少数新冠病毒感染引起的急性暴发性心肌炎患者对类固醇治疗有反应,糖皮质激素和免疫球蛋白治疗后病情有所改善。

结论

尽管全球范围内爆发了新冠疫情,但当前文献中报道的病例数量有限。在新冠病毒感染背景下,急性心肌炎的鉴别诊断存在诸多困难。

相似文献

1
COVID-19 and acute myocarditis: current literature review and diagnostic challenges.新型冠状病毒肺炎与急性心肌炎:当前文献综述及诊断挑战
Rev Assoc Med Bras (1992). 2020 Sep 21;66Suppl 2(Suppl 2):48-54. doi: 10.1590/1806-9282.66.S2.48. eCollection 2020.
2
Coronavirus-induced myocarditis: A meta-summary of cases.冠状病毒性心肌炎:病例汇总分析。
Heart Lung. 2020 Nov-Dec;49(6):681-685. doi: 10.1016/j.hrtlng.2020.08.013. Epub 2020 Aug 20.
3
Fulminant myocarditis due to COVID-19.新型冠状病毒肺炎所致暴发性心肌炎
Rev Esp Cardiol (Engl Ed). 2020 Jun;73(6):503-504. doi: 10.1016/j.rec.2020.04.005. Epub 2020 Apr 15.
4
Myocarditis in a 16-year-old boy positive for SARS-CoV-2.一名16岁SARS-CoV-2检测呈阳性男孩的心肌炎
Lancet. 2020 Jun 27;395(10242):e116. doi: 10.1016/S0140-6736(20)31307-6.
5
First case of COVID-19 complicated with fulminant myocarditis: a case report and insights.首例 COVID-19 合并暴发性心肌炎:病例报告及启示
Infection. 2020 Oct;48(5):773-777. doi: 10.1007/s15010-020-01424-5. Epub 2020 Apr 10.
6
COVID-19 (SARS-CoV-2) and the Heart - An Ominous Association.新型冠状病毒肺炎(严重急性呼吸综合征冠状病毒2)与心脏——一种不祥的关联。
Cardiovasc Revasc Med. 2020 Aug;21(8):946-949. doi: 10.1016/j.carrev.2020.05.009. Epub 2020 May 15.
7
Coronavirus disease 2019 (Covid-19) presenting as purulent fulminant myopericarditis and cardiac tamponade: A case report and literature review.2019 年冠状病毒病(COVID-19)表现为脓性暴发性心肌炎和心脏压塞:病例报告及文献复习。
Heart Lung. 2020 Nov-Dec;49(6):858-863. doi: 10.1016/j.hrtlng.2020.06.003. Epub 2020 Jun 9.
8
Life-threatening cardiac tamponade complicating myo-pericarditis in COVID-19.危及生命的心包填塞使新冠肺炎患者的心肌心包炎病情复杂化。
Eur Heart J. 2020 Jun 7;41(22):2130. doi: 10.1093/eurheartj/ehaa253.
9
A misleading CMV myocarditis during the COVID-19 pandemic: case report.COVID-19大流行期间的一例误导性巨细胞病毒心肌炎:病例报告
Pan Afr Med J. 2020 Jul 9;36:167. doi: 10.11604/pamj.2020.36.167.23922. eCollection 2020.
10
First Documentation of Persistent SARS-Cov-2 Infection Presenting With Late Acute Severe Myocarditis.首例持续性 SARS-CoV-2 感染致迟发性急性重症心肌炎的文献报道。
Can J Cardiol. 2020 Aug;36(8):1326.e5-1326.e7. doi: 10.1016/j.cjca.2020.06.005. Epub 2020 Jun 6.

引用本文的文献

1
Myocarditis and Myocardial Injury in Long COVID Syndrome: A Comprehensive Review of the Literature.长新冠综合征中的心肌炎和心肌损伤:文献综述
Cureus. 2023 Jul 25;15(7):e42444. doi: 10.7759/cureus.42444. eCollection 2023 Jul.
2
Veno-Arterial Extracorporeal Membrane Oxygenation in Patients with Fulminant Myocarditis: A Review of Contemporary Literature.《暴发性心肌炎患者的静脉-动脉体外膜肺氧合:当代文献回顾》
Medicina (Kaunas). 2022 Feb 1;58(2):215. doi: 10.3390/medicina58020215.
3
A case of fulminant myocarditis due to COVID-19 in an adolescent patient successfully treated with venous arterial ECMO as a bridge to recovery.
一例因 COVID-19 引起的暴发性心肌炎在青少年患者中成功接受静脉动脉体外膜肺氧合(ECMO)治疗作为恢复的桥梁。
J Card Surg. 2022 May;37(5):1439-1443. doi: 10.1111/jocs.16313. Epub 2022 Feb 13.
4
SARS-CoV-2 and Myocardical Injury with ST-Elevation without Coronary Disease.严重急性呼吸综合征冠状病毒2与无冠心病的ST段抬高型心肌损伤
Arq Bras Cardiol. 2021 Aug;117(2):411-414. doi: 10.36660/abc.20201268.
5
Pharmacotherapeutic agents for the management of COVID-19 patients with preexisting cardiovascular disease.治疗 COVID-19 合并心血管疾病患者的药物治疗。
Expert Opin Pharmacother. 2021 Dec;22(18):2455-2474. doi: 10.1080/14656566.2021.1960311. Epub 2021 Aug 31.
6
Anticoronavirus and Immunomodulatory Phenolic Compounds: Opportunities and Pharmacotherapeutic Perspectives.抗冠状病毒和免疫调节酚类化合物:机遇与药物治疗前景
Biomolecules. 2021 Aug 23;11(8):1254. doi: 10.3390/biom11081254.
7
Focal myocarditis in a young male with SARS-CoV-2 infection.一名感染新冠病毒的年轻男性的局灶性心肌炎。
Oxf Med Case Reports. 2021 Feb 15;2021(2):omaa142. doi: 10.1093/omcr/omaa142. eCollection 2021 Feb.
8
Electrocardiographic markers of increased risk of sudden cardiac death in patients with COVID-19 pneumonia.COVID-19 肺炎患者中与心源性猝死风险增加相关的心电图标记物。
Ann Noninvasive Electrocardiol. 2021 May;26(3):e12824. doi: 10.1111/anec.12824. Epub 2021 Jan 19.